Rigel Pharmaceuticals (RIGL) Research & Development (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted Research & Development of $13.96 million for Q2 2026, up 104.7% from $6.82 million a year earlier and up 19.6% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Rigel Pharmaceuticals was $43.68 million, up 61.3% year-over-year; for FY2025, it was $33.3 million, up 42.4% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- In prior years, Rigel Pharmaceuticals' Research & Development was $23.38 million in FY2024 (-4.7%), $24.52 million in FY2023 (-59.3%), $60.27 million in FY2022 (-7.6%) and $65.24 million in FY2021 (+8.5%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q4 2022.
- On a year-over-year basis, Research & Development has increased in each of the last seven quarters, with growth averaging 48.4% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2026, with growth of 104.7%; the weakest was Q4 2023, with a decline of 79.3%.
- According to Business Quant data, Research & Development for the three prior quarters was $11.68 million (Q1 2026), $10.69 million (Q4 2025) and $7.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Rigel Pharmaceuticals | 801.35 Mn | 305.08 Mn | 70.11 Mn | 18.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.27 Mn |
| Jun 30, 2026 | 13.96 Mn |
| Mar 31, 2026 | 11.68 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Sep 30, 2025 | 7.35 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Mar 31, 2025 | 8.44 Mn |
| Dec 31, 2024 | 5.63 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 6.48 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | 10.09 Mn |
| Dec 31, 2022 | 15.37 Mn |
| Sep 30, 2022 | 14.67 Mn |
| Jun 30, 2022 | 14.77 Mn |
| Mar 31, 2022 | 15.47 Mn |
| Dec 31, 2021 | 13.30 Mn |
API Access
Rigel Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();